Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.

ABSTRACT:

SUBMITTER: Vellas C 

PROVIDER: S-EPMC9307285 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature